Ekaterina I Alexeeva

7PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthOphthalmologyImmunogenetics (incl. genetic immunology)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
Effectiveness and Safety of Rituximab in Patients with Refractory Juvenile Idiopathic Arthritis: A Tertiary Center Experience.

|Jan 28, 2026
Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare.

Ekaterina I Alexeeva, Irina T Tsulukiya, Tatyana M Dvoryakovskaya

|Jan 28, 2026
Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period.

Ekaterina I Alexeeva, Tatiana M Dvoryakovskaya, Irina P Nikishina

|Aug 01, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Hermine I Brunner, César Pacheco-Tena, Ingrid Louw

|Dec 30, 2023
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study].

M S Lebedkina, D S Fomina, Z Y Mutovina

|Dec 30, 2023
[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic].

S N Avdeev, V P Chulanov, E I Alexeeva

Pageof 2

Frequent Collaborators

3 joint publications

D S Fomina

3 joint publications

Z Y Mutovina

3 joint publications

Mikhail M Kostik

3 joint publications

Elizaveta A Krekhova